Banks Hesitant on Bitcoin Amid Regulatory Hurdlesby John Darbie 04.09.2024U.S. regulatory challenges deter banks from embracing Bitcoin as a new asset class, says Cantor Fitzgerald CEO Howard Lutnick.
MicroStrategy’s Bitcoin Demand Sparks Overweight Ratingby John Darbie 22.08.2024Cantor sees Bitcoin's future value rising, boosting MicroStrategy's stock outlook with an Overweight rating.
Is Marvell the Top AI Semiconductor Stock Before Earnings?by Lilu Anderson 11.08.2024Marvell Technology's AI potential and projections make it a stock to watch, despite mixed Q1 results and market competition.
AbbVie Sets $1.55 Quarterly Dividend, Piper Sandler Ups Targetby Mark Eisenberg 22.06.2024AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...
Riot Platforms Amends Severance Terms, Expands Stock Poolby Mark Eisenberg 20.06.2024"Riot Platforms expands stock pool, updates severance terms for execs, and doubles authorized shares to 680M for future growth in ...
Top Stocks to Watch: Best Buy, GameStop, Micron Analysisby Mark Eisenberg 18.06.2024Discover why Best Buy, GameStop, and Micron Technology are stocks to watch this week with upgrades, shareholder buzz, and strong ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
SoundHound AI Stock: Big Red Flags Raisedby Mark Eisenberg 31.03.2024SoundHound AI stock has been performing exceptionally well, but there are major concerns about its future prospects. Investing in it ...